We previously found that miRNA treatment of MSCs can affect their proliferation and function (13, 14); IL-1β pretreatment can enhance the migration ability and immunosuppressive effect of MSCs (15), and exosomal miR-146a contributes to the enhanced therapeutic efficacy of IL-1β-primed MSCs against sepsis (12). Here, IL1B is linked to Sepsis.